Showing results (91-100 of 102) with videos related to
Sort By:
Pageof 11
Nature Communications|December 6, 2019
Infectious stimuli promote malignant B-cell acute lymphoblastic leukemia in the absence of AIDGuillermo Rodríguez-Hernández, Friederike V Opitz, Pilar Delgado, et al.European Journal of Human Genetics : EJHG|March 12, 2015
Redefining the MED13L syndromeAbidemi Adegbola, Luciana Musante, Bert Callewaert, et al.Cancer Research|June 21, 2017
Infection Exposure Promotes <i>ETV6-RUNX1</i> Precursor B-cell Leukemia via Impaired H3K4 DemethylasesGuillermo Rodríguez-Hernández, Julia Hauer, Alberto Martín-Lorenzo, et al.Cell Death & Disease|September 29, 2021
The long non-coding RNA HOTAIRM1 promotes tumor aggressiveness and radiotherapy resistance in glioblastomaUlvi Ahmadov, Daniel Picard, Jasmin Bartl, et al.Journal for Immunotherapy of Cancer|January 13, 2023
Tacedinaline (CI-994), a class I HDAC inhibitor, targets intrinsic tumor growth and leptomeningeal dissemination in MYC-driven medulloblastoma while making them susceptible to anti-CD47-induced macrophage phagocytosis via NF-kB-TGM2 driven tumor inflammationViktoria Marquardt, Johanna Theruvath, David Pauck, et al.Brain : a Journal of Neurology|October 21, 2017
Rare GABRA3 variants are associated with epileptic seizures, encephalopathy and dysmorphic featuresCristina Elena Niturad, Dorit Lev, Vera M Kalscheuer, et al.Nature Communications|July 13, 2022
The HHIP-AS1 lncRNA promotes tumorigenicity through stabilization of dynein complex 1 in human SHH-driven tumorsJasmin Bartl, Marco Zanini, Flavia Bernardi, et al.American Journal of Human Genetics|April 30, 2013
ZC4H2 mutations are associated with arthrogryposis multiplex congenita and intellectual disability through impairment of central and peripheral synaptic plasticityHiromi Hirata, Indrajit Nanda, Anne van Riesen, et al.Human Mutation|November 12, 2014
Variants in CUL4B are associated with cerebral malformationsAnneke T Vulto-van Silfhout, Tadashi Nakagawa, Nadia Bahi-Buisson, et al.Nature Genetics|July 28, 2015
Genomics and drug profiling of fatal TCF3-HLF-positive acute lymphoblastic leukemia identifies recurrent mutation patterns and therapeutic optionsUte Fischer, Michael Forster, Anna Rinaldi, et al.Pageof 11